RCM Strategies to Explore for Genetic Testing Compliance
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
The $14.6 billion bust by federal prosecutors shows gaps that every laboratory should monitor
Learn how CLIA could be used as a blueprint to regulate emerging technologies in an effective and dynamic way
The $100 million deal will take advantage of LEX VELO technology to detect influenza and SARS-CoV-2
Washington State’s Department of Health details how its medical testing site program meets federal standards
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
We explain what ‘tokens’ are, as well as what ‘GPT’ really means
Clinical lab billing teams face an overwhelming number of challenges if revenue cycle strategies fall short
UPMC pathology leader discusses steps the lab takes to combat evolving cyber threats